Ledger.Open graph →
SEC Form D · filed October 26, 2018

Diasome Pharmaceuticals, Inc

Offering
$18.6M
Sold
$12.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CLEVELAND, OH
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (14)

Frank B. Mccaney · Cleveland, OHDirectorThomas B. Mcdonald · Cleveland, OHDirectorRobert Geho · Cleveland, OHExec · DirectorMarc Penn · Cleveland, OHDirectorW. Blair Geho · Cleveland, OHDirectorWilliam V. Oxford · Austin, TXExec · DirectorPaul S. Nixon · Austin, TXDirectorJames S. Gable · Austin, TXDirectorRichard T. O?Toole · NEW YORK, NYDirectorBrian Michaud · Teaneck, NJExec · DirectorWill Mcdavid · Teaneck, NJDirectorBrian D'Amico · Teaneck, NJDirectorVikram S. Uppal · NEW YORK, NYDirectorW. Blair Geho · Cleveland, OHDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗

Diasome Pharmaceuticals, Inc. — SEC Form D filing (2018) | Ledger